Anesthetic drugs & techniques

Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis

Br J AnaesthPublished Systematic review and meta-analysis of randomised trials

Pooled result · Sedation success rateResult — go to the resultRR for sedation success 0.991 95% CI 0.984–0.998

Authors' conclusion

Remimazolam has clinically similar efficacy and greater safety when compared with propofol for sedation in gastrointestinal endoscopies.

Study context

Population
Adults undergoing sedation for gastrointestinal endoscopy
Participants
4,516 adults · 15 trials
Comparison
Remimazolam vs propofol, both combined with a short-acting opioid
Outcome
Sedation success rate
Methodological detailssensitivity analyses, subgroup analyses by opioid type and age range, meta-regression by mean patient age
  • Sensitivity analyses
  • Subgroup analyses by opioid type and age range
  • Meta-regression by mean patient age

Pooled result

As reported in the abstract

RR for sedation success

0.991

95% CI 0.984–0.998

Remimazolam vs Propofol
RR for sedation success 0.991 (95% CI 0.984–0.998)

Further pooled results

OutcomeMD (s) (95% CI)
Induction timeSlightly longer with remimazolam; moderate-quality evidence9 (4–13)

Other time-related outcomes

No significant difference between the sedatives

Patient satisfaction

No difference between both drugs
MD 0.41 (−0.07 to 0.89) (95% CI)
  • Moderate-quality evidence

Endoscopist satisfaction

No difference between both drugs
MD −0.31 (−0.65 to 0.04) (95% CI)
  • High-quality evidence

Safety

OutcomeRR (95% CI)
Respiratory depressionHigh-quality evidence0.41 (0.30–0.56)
HypotensionModerate-quality evidence0.43 (0.35–0.51)
Hypotension requiring treatmentHigh-quality evidence0.25 (0.12–0.52)
BradycardiaHigh-quality evidence0.42 (0.30–0.58)

Original publication

Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth. Published 4 March 2024. doi:10.1016/j.bja.2024.02.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.